The First Affiliated Hospital Of Xiamen University

This early-stage study is testing a combination of two drugs—peginterferon alfa-2b and an anti-PD-1 antibody—in about 60 people with advanced solid tumors that have stopped responding to standard treatments. The main goal is to find the safest dose and see if the combination can …

This early study tests whether transplanting gut bacteria from young donors (fecal transplant) can make standard immunotherapy and chemotherapy work better for people with advanced colorectal cancer that hasn't responded to prior treatment. Ten patients will receive the combinati…

This study looks at whether semaglutide, a common diabetes drug, affects bone density and fracture risk in people with type 2 diabetes. About 150 adults aged 50-75 with low bone mass or a recent fracture will take either semaglutide plus metformin or metformin alone for 12 months…

This study tests a new combination of drugs (pyrotinib, darcilib, and standard hormone therapy) given before surgery to people with a common type of breast cancer (HR+HER2 low). The goal is to see if this approach shrinks tumors more effectively. About 33 participants will receiv…

This study will test whether two types of PET/CT scans can more accurately stage nasopharyngeal cancer and predict how well patients will respond to immunotherapy before treatment. Researchers will observe 732 adults with newly diagnosed cancer, measuring tumor activity on scans …